Evaluating a CLL susceptibility variant in in families with multiple subtypes of hematological malignancies.
作者信息
Blackburn Nicholas B, Marthick James R, Banks Annette, Charlesworth Jac C, Marsden Katherine A, Lowenthal Ray M, Blangero John, Dickinson Joanne L
机构信息
South Texas Diabetes and Obesity Institute, School of Medicine, University of Texas Rio Grande Valley, Brownsville, TX.
Menzies Institute for Medical Research, University of Tasmania, Hobart, TAS, Australia; and.
出版信息
Blood. 2017 Jul 6;130(1):86-88. doi: 10.1182/blood-2017-03-774232. Epub 2017 May 10.
Abstract
摘要
相似文献
1
Evaluating a CLL susceptibility variant in in families with multiple subtypes of hematological malignancies.
Blood. 2017 Jul 6;130(1):86-88. doi: 10.1182/blood-2017-03-774232. Epub 2017 May 10.
2
Evidence for a common genetic aetiology in high-risk families with multiple haematological malignancy subtypes.
Br J Haematol. 2010 Aug;150(4):456-62. doi: 10.1111/j.1365-2141.2010.08267.x. Epub 2010 Jun 15.
3
Familial B-cell chronic lymphocytic leukemia in a population of patients from Southern Italy.
Int J Hematol. 2004 May;79(4):354-7. doi: 10.1532/ijh97.e0304.
4
Evaluation of Patients and Families With Concern for Predispositions to Hematologic Malignancies Within the Hereditary Hematologic Malignancy Clinic (HHMC).
Clin Lymphoma Myeloma Leuk. 2016 Jul;16(7):417-428.e2. doi: 10.1016/j.clml.2016.04.001. Epub 2016 Apr 27.
5
Prevalence of familial malignancy in a prospectively screened cohort of patients with lymphoproliferative disorders.
Br J Haematol. 2008 Nov;143(3):361-8. doi: 10.1111/j.1365-2141.2008.07355.x. Epub 2008 Aug 20.
6
An overview of genetic predisposition to familial hematological malignancies.
Bull Cancer. 2021 Jul-Aug;108(7-8):718-724. doi: 10.1016/j.bulcan.2021.03.013. Epub 2021 May 26.
7
Frequency of hematologic and solid malignancies in the family history of 50 patients with acute myeloid leukemia - a single center analysis.
PLoS One. 2019 Apr 18;14(4):e0215453. doi: 10.1371/journal.pone.0215453. eCollection 2019.
8
ARLTS1, potential candidate gene in familial aggregation of hematological malignancies.
Bull Cancer. 2017 Feb;104(2):123-127. doi: 10.1016/j.bulcan.2016.10.016. Epub 2016 Nov 17.
9
The influence of MTHFR C677T polymorphism in chronic lymphocytic leukemia.
Electrophoresis. 2019 Jul;40(12-13):1715-1718. doi: 10.1002/elps.201800402. Epub 2019 May 2.
10
Intragenic Variations in BTLA Gene Influence mRNA Expression of BTLA Gene in Chronic Lymphocytic Leukemia Patients and Confer Susceptibility to Chronic Lymphocytic Leukemia.
Arch Immunol Ther Exp (Warsz). 2016 Dec;64(Suppl 1):137-145. doi: 10.1007/s00005-016-0430-x. Epub 2016 Dec 8.
引用本文的文献
1
Recent Advances in Gene Therapy for Hemophilia: Projecting the Perspectives.
Biomolecules. 2024 Jul 15;14(7):854. doi: 10.3390/biom14070854.
2
Inhibitory effect of on atherosclerosis through the p53 pathway.
Ann Transl Med. 2022 Sep;10(18):1008. doi: 10.21037/atm-22-4372.
3
Key immune-related gene ITGB2 as a prognostic signature for acute myeloid leukemia.
Ann Transl Med. 2021 Sep;9(17):1386. doi: 10.21037/atm-21-3641.
4
Shared genomic segment analysis in a large high-risk chronic lymphocytic leukemia pedigree implicates in inherited risk.
J Transl Genet Genom. 2021;5:189-199. doi: 10.20517/jtgg.2021.05. Epub 2021 Jun 15.
5
Prevention and Management of Bleeding Episodes in Patients with Acquired Hemophilia A.
Drugs. 2018 Dec;78(18):1861-1872. doi: 10.1007/s40265-018-1027-y.
6
Analysis of rare germ line variants in chronic lymphocytic leukemia.
Blood. 2017 Nov 30;130(22):2443-2444. doi: 10.1182/blood-2017-08-800128. Epub 2017 Oct 19.
本文引用的文献
1
Discussing and managing hematologic germ line variants.
Blood. 2016 Nov 24;128(21):2497-2503. doi: 10.1182/blood-2016-06-716704.
2
Whole exome sequencing in families with CLL detects a variant in Integrin β 2 associated with disease susceptibility.
Blood. 2016 Nov 3;128(18):2261-2263. doi: 10.1182/blood-2016-02-697771. Epub 2016 Sep 14.
3
Analysis of protein-coding genetic variation in 60,706 humans.
Nature. 2016 Aug 18;536(7616):285-91. doi: 10.1038/nature19057.
4
Whole exome sequencing in families at high risk for Hodgkin lymphoma: identification of a predisposing mutation in the KDR gene.
Haematologica. 2016 Jul;101(7):853-60. doi: 10.3324/haematol.2015.135475. Epub 2016 Jun 13.
5
A retrospective examination of mean relative telomere length in the Tasmanian Familial Hematological Malignancies Study.
Oncol Rep. 2015 Jan;33(1):25-32. doi: 10.3892/or.2014.3568. Epub 2014 Oct 24.
6
Guidelines for investigating causality of sequence variants in human disease.
Nature. 2014 Apr 24;508(7497):469-76. doi: 10.1038/nature13127.
7
The Familial Tasmanian Haematological Malignancies Study (FaTHMS): its origins, its history and the phenomenon of anticipation.
Transfus Apher Sci. 2013 Oct;49(2):113-5. doi: 10.1016/j.transci.2013.07.011. Epub 2013 Aug 19.
8
Hematologically important mutations: leukocyte adhesion deficiency (first update).
Blood Cells Mol Dis. 2012 Jan 15;48(1):53-61. doi: 10.1016/j.bcmd.2011.10.004. Epub 2011 Nov 30.
9
Evidence for a common genetic aetiology in high-risk families with multiple haematological malignancy subtypes.
Br J Haematol. 2010 Aug;150(4):456-62. doi: 10.1111/j.1365-2141.2010.08267.x. Epub 2010 Jun 15.
10
Multipoint quantitative-trait linkage analysis in general pedigrees.
Am J Hum Genet. 1998 May;62(5):1198-211. doi: 10.1086/301844.
Zotero 插件